EUVIMEDEUVIMED entdecken
Crossref

Thioredoxin attenuates ischemia–reperfusion–induced pressure ulcer formation by enhancing HIF-1α/BNIP3-dependent mitophagy and suppressing MAPK/NF-κB signaling

Zhenlong Ji, Jueyi Zhang, Jionghao Sheng, Pan Li, Ying Huang, Aojie Chen, Yingfei Zhu, Fengwen Zhao, Yaxuan Wang, Zekai Zhu, Yike Shou, Jinxiong Lv und 8 weitere

Archives of Biochemistry and Biophysics · 2026-08 · 782 · 110843

DOI: 10.1016/j.abb.2026.110843 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2026-08. Verfasst von Zhenlong Ji und 19 weiteren Autor:innen. Beteiligte Einrichtung: School of Life and Environmental Sciences, Shaoxing University, Shaoxing, China. Hauptthemen laut MEDLINE: Thioredoxins, NF-kappa B, Reperfusion Injury, Hypoxia-Inducible Factor 1, alpha Subunit. Die Arbeit nennt 77 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ischemia-reperfusion (I/R) injury plays a pivotal role in the pathogenesis of pressure ulcer formation. In I/R microenvironments, mitophagy serves as an essential cellular self-protection mechanism for clearing damaged mitochondria and preventing apoptosis and inflammatory responses; the HIF-1α/BNIP3 signaling pathway acts as the central hub regulating this process. Thioredoxin (TRX), a critical redox-regulatory protein, has shown protective effects in I/R-related diseases, but its role in cutaneous I/R injury remains unclear. In this study, we investigated whether recombinant human TRX (rhTRX) alleviates I/R-induced skin injury and explored the underlying mechanisms using a murine pressure ulcer model and an in vitro keratinocyte I/R model. rhTRX treatment significantly reduced tissue damage, neutrophil infiltration, and the levels of pro-inflammatory cytokines (IL-1β, TNF-α, IL-6), the oxidative stress marker 8-OHdG, and apoptosis-related proteins (BAX, cleaved caspase-3), while increasing BCL-2 expression. Mechanistically, rhTRX suppressed intracellular ROS production and increased GSH level, it also inhibited MAPK/NF-κB signaling, thereby attenuating mitochondria-mediated inflammation and apoptosis. In addition, rhTRX preserved mitochondrial integrity by reducing cytochrome c and mitochondrial DNA release. Notably, rhTRX enhanced HIF-1α/BNIP3/LC3II-dependent mitophagy, and HIF-1α silencing partially abolished these protective effects. In conclusion, rhTRX mitigates cutaneous I/R injury by reducing oxidative stress and inflammation and by promoting mitophagy-mediated mitochondrial quality control. These findings suggest that topical TRX represents a potential therapeutic strategy for pressure ulcer prevention and treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThioredoxinsNF-kappa BReperfusion InjuryHypoxia-Inducible Factor 1, alpha SubunitMitophagyPressure UlcerMembrane ProteinsMAP Kinase Signaling SystemAnimalsMiceHumansSignal TransductionMaleRecombinant ProteinsApoptosisMice, Inbred C57BL

Stichwörter der Autor:innen

ApoptosisInflammationIschemia–reperfusion injuryMitophagyPressure ulcerThioredoxin

Substanzen

ThioredoxinsNF-kappa BHypoxia-Inducible Factor 1, alpha SubunitMembrane ProteinsRecombinant Proteins

Autor:innen und Institutionen

  • School of Life and Environmental Sciences, Shaoxing University, Shaoxing, China.
  • Department of Basic Medicine, Medical College, Shaoxing University, Shaoxing, China.
  • Civil Engineering School, Shaoxing University, Shaoxing, China.
  • Department of Dermatology, Division of Medicine for Function and Morphology of Sensory Organs, Faculty of Medicine, Osaka Medical and Pharmaceutical University, Daigaku-cho, Takatsuki, Japan.
  • Department of Biological Response, Laboratory of Infection and Prevention, Institute for Virus Research, Kyoto University, Kyoto, Japan.
  • Department of Breast Surgery, Misugikai Sato Hospital, Hirakata, Japan.

Zitieren

APA

Ji, Z., Zhang, J., Sheng, J., Li, P., Huang, Y., Chen, A., Zhu, Y., Zhao, F., Wang, Y., Zhu, Z., Shou, Y., Lv, J., Shentu, N., Cao, J., Shi, T., Zhu, X., Fukunaga, A., Yodoi, J., Yamauchi, A., & Tian, H. (2026). Thioredoxin attenuates ischemia–reperfusion–induced pressure ulcer formation by enhancing HIF-1α/BNIP3-dependent mitophagy and suppressing MAPK/NF-κB signaling. Archives of Biochemistry and Biophysics, 782, 110843. https://doi.org/10.1016/j.abb.2026.110843

Vancouver

Ji Z, Zhang J, Sheng J, Li P, Huang Y, Chen A, et al. Thioredoxin attenuates ischemia–reperfusion–induced pressure ulcer formation by enhancing HIF-1α/BNIP3-dependent mitophagy and suppressing MAPK/NF-κB signaling. Archives of Biochemistry and Biophysics. 2026;782:110843. doi:10.1016/j.abb.2026.110843

BibTeX
@article{Ji2026,
  author = {Ji, Zhenlong and Zhang, Jueyi and Sheng, Jionghao and Li, Pan and Huang, Ying and Chen, Aojie and Zhu, Yingfei and Zhao, Fengwen and Wang, Yaxuan and Zhu, Zekai and Shou, Yike and Lv, Jinxiong and Shentu, Nanhong and Cao, Jiayi and Shi, Tingyu and Zhu, Xinting and Fukunaga, Atsushi and Yodoi, Junji and Yamauchi, Akira and Tian, Hai},
  title = {Thioredoxin attenuates ischemia–reperfusion–induced pressure ulcer formation by enhancing HIF-1α/BNIP3-dependent mitophagy and suppressing MAPK/NF-κB signaling},
  journal = {Archives of Biochemistry and Biophysics},
  year = {2026},
  volume = {782},
  pages = {110843},
  doi = {10.1016/j.abb.2026.110843}
}
Kostenlos starten →